Results and Discussion
Initially, we examined distinct tumor target cell lines (15, 19) for cytolysis by these clones (Table 1) . Clones selected by FACS for TCRy/b expression from a culture primed to the LCL TK6 mediated a very high level of cytotoxicity on Daudi cells but failed to lyse the Raji cell line (Table I) . In marked contrast, NK clones obtained from PBL of the same donor lysed the Daudi and Raji targets equally well (Table   II) . Disparate lysis of these two target lines by y/S clones and NK clones was remarkable since both Daudi and Raji are quite similar cells derived from Burkitt's lymphomas . The Daudi cell line is deficient for HLA class I antigens due to defective (32m synthesis but expresses HLA class II antigens, while Raji expresses both HLA class I and II . Although-non-MHC-restricted lysis appears to correlate inversely with the expression of HLA class I antigens on some target cells (20, 21) , this does Clones Obtained by Sortingfor TCR-y/8-1 + Cells from Primed Culture
The clones were derived from a culture of PBL primed to the LCL TK6 for 7 d followed by FACS sorting for TCR-y/b' cells . Clones were screened for cytotoxicity on the indicated target cell lines . The results indicating percent cytotoxicity were obtained in experiments where equal volumes (25 pl) of medium in wells containing the clones were transferred to plates to which the target cells were subsequently added . Two or three replicates were performed per clone ; SD for percent cytotoxicity was usually <3% . Autologous y/b clones and NK clones were simultaneously compared . The experiments in Tables I, II , IV, and VI represent 2 of 24 similar experiments . The phenotypes of the clones in Table I Table I . not provide an explanation for the particular pattern of cytotoxicity by these 'r/6 clones . First, virtually all NK clones lysed Raji as well as or even better than Daudi targets and, second, an HLA class I-expressing Daudi variant was strongly killed by all they/b clones (Table III) . All y/b clones and NK clones mediated non-MHCrestricted cytolysis against HLA antigen-deficient K562 target cells. Both NK and The clones were derived from fresh PBL sorted for CD16 (Leu-11)' cells. LCL used as stimulators were TK6 . Clones were screened for cytotoxicity on the indicated target cell lines . The results indicating percent cytotoxicity were obtained in experiments where equal volumes (25 pl) of medium in wells containing the clones were transferred to plates to which the target cells were subsequently added. Two or three replicates were performed per clone ; SD for cytotoxicity was usually <3% . Autologous y/b clones and NK clones were simultaneously compared . The phenotypes of the clones in Table II were determined by direct immunofluorescence . Values shown for binding of mAbs are expressed as percent positive cells, and data are rounded to the decimal point . Clone type designations are defined as in Table I . The results shown reflect  typical response patterns selected from 90 clones evaluated for Table II .   Percent specific binding of mAb  Percent cytotoxicity  Clone  Type  CD3  TCR-61  CD16 CD56 CD4  CD8  K562  Daudi  Raji  TK6  GPC4  y/5  99  100  0  39  0  95  42  53  2 Raji  TK6  NAD1  NK  2  0  94  99  82  54  47  52  NAA1  NK  1  0  91  97  83  81  86  23  NAM  NK  1  ND  93  99  73  75  85  59  NAC2  NK  3  ND  99  99  61  11  53  31  NEE6  NK  2  ND  98  96  86  41  46  25  NEEI  NK  1  ND  99  99  90  55  60  54 TABLE III Target Selectivity of Representative Clones Percent cytotoxicity mediated by 10 representative clones is shown at three E/T ratios when tested for lysis against the six target cell lines indicated . The clone type designations are listed as in Table 1 . LCL indicates the particular stimulator LCL for each of these clones .
.y/S T cell clones also lysed the cell lines TK6, Molt4 (Tables I-V) , and U937 (not shown) . However, in contrast to NK clones, lysis of these target cells was weaker than the cytotoxicity against Daudi cells iflower E/T ratios were compared (Table III) . This characteristic cytotoxic pattern was independent of priming to the LCL TK6 in vitro before FACS selection. Clones obtained after sorting offresh PBL for TCR y/6-1 + cells and stimulation with different feeder LCL (including the autologous LCL) had an identical pattern of cytotoxicity (Table IV) . All 356 -Y/6 clones that were obtained from this donor's fresh PBL without "priming" to TK6 mediated high levels oflysis on Daudi cells but virtually no killing on the Raji cell line . These clones The clones were derived from fresh PBL sorted for TCR-'y/b-1 + cells . LCL used as stimulator cells were PF-, PS-, and RM-LCL for clones with initials F, P, and M, respectively . Clones were screened for cytotoxicity on the indicated target cell lines including the specific stimulator LCL . The results indicate percent cytotoxicity were obtained in experiments where equal volumes (25 Wl) of medium in wells containing the clones were transferred to plates to which the target cells were subsequently added . Two or three replicates were performed per clone ; SD for percent cytotoxicity was usually <3% . Autologous y/b clones and NK clones were simultaneously compared . The phenotypes of the clones in Table IV were determined by indirect immunofluorescence . Values shown for binding of mAbs are expressed as percent positive cells, and data are rounded to the decimal point . Clone type designations are defined as in Table I . The results shown reflect typical response patterns selected from 211 clones evaluated for Table IV . also killed K562, and many but not all clones also effectively destroyed TK6. However, these y/b clones did not lyse the particular LCL used to stimulate them, except for TK6. These stimulator LCL were susceptible to cytolysis by NK clones and alloreactive a/a T cell clones . The exclusive pattern ofcytotoxicity by these y/b T cell clones was reproduced in >40 experiments with some ofthese clones . Moreover, analogous results were obtained when these same y/b clones (seven of seven) were tested in Rotterdam on TK6 cells and on independently maintained K562, Daudi, Raji, and LCL targets. In contrast to these y/b clones, all TCRa/(3 clones with non-MHCrestricted cytotoxic activity against K562 that were obtained from the same donor (33 clones) did not lyse Daudi or Raji cells, although many clones lysed Molt4 and/or TK6 targets (representative clones shown in Tables III and IV) . Phenotypic analysis with mAbs (Tables I, II , IV, and V Figure 1 ) identified the NK clones as Leu-11a (CD16)' or Leu-11a-and Leu-19 (CD56)+, but TCR61 -while they/b clones were TCRy/b-1+, TCRb1 + (mAbs reactive with ally/b cells [8, 16] ). Most y/b T cell clones were double negative for CD4 and CD8, but some clones expressed variable levels ofCD8. Particularly striking were rare clones that markedly lysed Raji, obtained from cells that had been sorted for TCR'y/b-1 + . All of these were subsequently proven to be NK clones rather than y/b T cell clones (presumably contaminants in the sorted cells, i.e., clone GAB1; Table I , Fig. 1 ). Furthermore, some clones that were derived from a sort for Leu-19+ PBL mediated the pattern of lysis corresponding to that of the ti/b clones (Table V) . Indeed, all such clones were shown to be Leu-19' y/b T cell clones and not NK clones ; clones that displayed The clones were derived from fresh PBL sorted for Leu-19 (CD56)' cells . LCL used as stimulator cells were TK6 . Clones were screened for cytotoxicity on the indicated target cell lines . The results indicating percent cytotoxicity were obtained in experiments where equal volumes (25 Al) of medium in wells containing the clones were transferred to plates to which the target cells were subsequently added . Two or three replicates were performed per clone ; SD for percent cytotoxicity was usually <3% . Autologous . y/S clones and NKclones were simultaneously compared in each experiment . The phenotypes of the clones in Table V were determined by indirect immunofluorescence . Values shown for binding of mAbs are expressed as percent positive cells, and data are rounded to the decimal point . Clone type designations are defined as in Table I . The results shown reflect typical response patterns selected from 338 clones evaluated for Table V . a different pattern of cytotoxicity were proven to be NK clones or, rarely, TCR a/(3 clones . 20 representative y/S clones were phenotyped with additional mAbs that react with specific V region-encoded protein products and thus detect functional TCR gene rearrangements. As described for the majority of peripheral blood y /S cells (16) , all 20 clones were TiyA+ (reactive with Vy9 [17] ) and BB3 + (reactive with V62 [18] ). However, all these clones lacked the determinant recognized-by mAb STCS1 (reactive with VS1 [16] ) . The phenotype of these clones is consistent with the FRCS analysis of this donor's peripheral blood y/S cells that seem BB3+ and TiyA+ , but are STCS1 -. Since the expression ofthe TCRy/S correlated with the particular pattern of cytotoxicity on these tumor cell lines, we investigated the role of the CD3/TCRy/S complex in target cell lysis (Figs. 2 and 3) . The effect of anti-CD3 mAb depended on FcR expression on target cells (5, 9, 22) . The antibody was inhibitory when included in the cytotoxicity assay with FcR-targets such as Molt 4 and TK6 (not shown), while the lysis of the FcR+ Daudi and Raji cells (Fig. 2) was enhanced due to crosslinking of the effector and target cells via FcR (9, 22 Tables I-III) were stained with fluorescent mAbs for direct immunofluorescence. 5,000 cells were analyzed by FACS for each mAb. The NK clones are designated RAD6 (CD16', Leu-19', CD2*, CD3-, TCR61 -) and GABI (CDI6-, Leu-19*, CD2*, CD3-, TCR Sl -); the y/6 clones are GPE5 (CD2*, CD3*, TCR61*, 8rCS1 -, BB3*, TiyA', CD4-, CD8-, CD16 -, Leu-19w°ak) and GPC4 (CD2*, CD3*, TCR-61 *, 6rCS1 -, BB3*, TiyA*, CD4-, CD8*, CDl6 -, Leu-19*) with Loglo fluorescence the additional markers not shown.
by anti-CD3 mAb indicates that the very inefficient lysis of Raji cells by effector y/6 T lymphocytes in the absence of anti-CD3 was due to nonrecognition rather than intrinsic resistance of Raji cells to the lytic machinery of these clones . Appropriate concentrations of the TCRy/6-1 mAb (which is of the same isotype as the anti-CD3 mAb) were inhibitory for the y/6 T cell-mediated lysis of Daudi, Molt 4, and, although less, for TK6 target cells (Figs. 2 and 3) . On the contrary and in agreement with published data (9, 23), the lysis of FcR' K562 and U937 target cells was augmented in the presence of TCR-y/6-1 mAb. Nevertheless, in some experiments, higher concentrations of the TCR-y/6-1 mAb had a mild inhibitory effect on the lysis of K562 (as shown in Fig. 3 ) and U937 cells (not shown) . This effect may result from a competition between stimulatory and inhibitory signals depending on the mAb, its concentration, and the mechanism of E/T cell interaction . The stimulatory signals may include in this system FcR mediated crosslinking (9, 22) and the augmentation of E/T adhesion through LFA-1 after CD3 crosslinking (24) . The inhibitory signals may be a consequence of the interference of the mAb with specific recognition structures on the effector cell and/or an intracellular negative signal affecting the efficacy of T cell stimulation (8, 25) . As the concentration of the TCR y/6-1 antibody increased, the inhibitory effects outweighed the inducing capacity on FCR+ targets and, thus, the overall results shifted towards inhibition . In contrast to some reported findings (26, 27) showing that only very low mAb concentrations were blocking the cytotoxic activity by y/S T cells against allogeneic lymphoblastoid cell lines (favoring the idea of transmission of a negative signal), we detected maximal inhibition at high concentrations. This is compatible with the view that the mAb interfered with the TCRmediated recognition and/or delivered negative signals. Molt4 targets (Fig. 4) . Although most of the TCR had been downmodulated by TCRy/S-1 or anti-CD3 pretreatment, a further exposure to anti-CD2 or anti-CD3 mAb, added in the beginning of the cytotoxicity assay, still resulted in strong lysis ofboth Raji and Daudi targets (Fig . 4) . Thus, the blocking of cytotoxicity by TCR--y/S-1 mAb was caused by neither a simple inhibition ofthe effectors' lytic machinery nor toxicity to the cell . The cytotoxic activity against Daudi cells, but not Raji cells, was displayed by all BB3/TiyA' y/S clones . This lytic pattern contrasts with the distinct target cell susceptibility found in NK clones and a//3 T cell clones . Moreover, lysis ofsome target cells can be blocked by TCRy/&-1 mAb while the lytic machinery of these cells appears intact . These results suggest that the CD3/TCRy/S complex on our y/6 T cell clones could be involved in the recognition of determinants on certain targets such as Daudi cells. The lysis of K562 and U937 cells by our 'Y/S clones was not effectively blocked in the presence of anti TCR mAb. It is difficult to determine ifthis apparent lack of antiTCR blocking oflysis resulted from a deficit of inhibitory signals or a predominance of stimulatory signals. Relevant to this may be the observation that the capacity of all y/S and a//3 clones to kill K562 and U937 disappeared when the clones were passaged in vitro for many weeks (although our y/S clones maintained the ability to lyse Daudi cells) . These findings may suggest that the cytotoxic activity by our y/S clones against K562 and U937 cells was medi- ated differently than that against Daudi. Our data corroborate recent results reporting a similar specificity of polyclonal BB3/TiyA+, STCS1 -T cell lines (23) and the inhibitory effects of antiTCR mAb on the lysis of K562, U937 (9, 23) , and Daudi cells (23) , as well as Molt 4 cells (9, 28) . Other investigators (27) have reported that the lysis of Molt 4 cells by allospecific STCS1 + -y/S T cell clones is augmented in the presence of anti-CD3 or STCSI mAb, and only Leu-19' displayed non-MHCrestricted activity. Their results are not necessarily in contrast to our data since our clones are clearly different: our clones are all 6TCSI -and mediate non-MHCrestricted cytotoxicity regardless of Leu-19 expression . An alternative explanation for blocking of cytotoxicity by antiTCR mAb could be negative signaling elicited by certain types of TCR occupancy. Since the TCR y/S may not be directly involved in the y/S T cell/target cell interaction, there is a possibility that the cell surface molecules mediating effector target cell adhesion (29) , such as LFA-1, ICAM-1, CD2, and LFA-3, are the essential recognition structures. However, we have found these receptors equally expressed on all y/S T cell clones, NK-, and a/j3 T cell clones examined, and we identified no ligand on Daudi (LFA-1 -, ICAM-1+, CD2 -, LFA-3 -) that was' not present on Raji (LFA-1+, ICAM-1 +, CD2-, LFA-3 +) (not shown) . Therefore, it seems quite unlikely that the differential expression of these molecules could account for the particular pattern of cytolysis displayed by our y/S T cell clones . Nevertheless, other yet unknown structures distinct from the TCR and these adhesion molecules could be functional in the lytic mechanism used by y/S T cells. Despite the great potential diversity of the TCRy/S (predominantly due to the junctional diversity of the S chain) (1, 2, 30, 31 ), the number of functional gene combinations utilized by human peripheral y/S T cells appears quite limited (16) (17) (18) . The cytotoxicity pattern by the BB3/Ti-yA+ y/S clones was the same when using clones obtained from two additional blood donors and comparing them with NK and a/J3 clones derived from each of these donors (not shown) . Furthermore, a similar target spectrum (lysis of Daudi but not the stimulator LCL) and the same productive Vy/S gene expression (assessed by mAb BB3 and TiyA) was independently detected in all TCRy/S-1 + , STCSI -clones derived from four different donors in Rotterdam . The results presented here strongly suggest that human BB3/TiyA + T cells recognize different determinants than non-MHC-restricted NK cells (3, 4) or IL-2-activated MHC-restricted a/o T cells (31) . The relationship of these target structures to known antigens for y/S T cells remains to be determined (12) (13) (14) 32) . However, these target structures cannot be related to HLA class I since Daudi cells do not express 02m-associated determinants . The target molecules are probably not typical HLA class II determinants since 25 allogeneic LCL including the stimulator LCL (except for TK6), which express a range of diverse class II antigens, were resistant to lysis by all our y/b clones (not shown) . Furthermore, mAbs directed against HLA-DR, -DP, or -DQ did not inhibit lysis of Daudi by these y/b cells (not shown) . It is noteworthy that ally/b clones that had been derived with autologous LCL and PBL stimulators, and thus were never exposed to allogeneic determinants in vitro, still mediated the typical pattern of cytolysis. These results support the idea that our y/b clones probably do not recognize polymorphic or nonpolymorphic MHC molecules as suggested for other y/b cells (26, 28, (33) (34) (35) . It is conceivable that our y/b cells could recognize relatively nonpolymorphic determinants that are expressed in sufficient quantities on only a minority of target cells. If the TCR-y/b is in fact the receptor that reacts to such determinants, it is possible that such epitopes function as "superantigens" for BB3/TiyA+ cells. Indeed, the epitopes on some tumor targets could be related to heat-shock proteins contained in mycobacterial preparations (12-14, 32, 36) . It will be interesting to compare the function and specificity of our BB3/TiyA+ clones with BTCSI + clones, other non-MHC-restricted cytolytic y/b T cells (26) (27) (28) , and clones derived from different tissues (30, 32) . Although the physiologic role and function of y/b T cells remains elusive, our data clearly indicate that the recognition of some target cells by our BB3/TiyA+ T cell clones is markedly different from other non-MHC-restricted lymphoid cells.
Summary
Non-MHC-restricted killer cells are cytotoxic lymphocytes that can mediate cytolysis of most tumor targets without apparent selectivity and restriction by the MHC, particularly when activated with IL-2. These effector cells include predominantly NK cells and T cells expressing the TCRy/& We found that TCRy/b-1+, BTSC1 -, BB3+, TiyA+ T cell clones mediate a characteristic cytolytic pattern of non-MHCrestricted cytolysis that is markedly different from NK clones and a/(3 T cell clones derived from the peripheral blood of the same normal individuals. The characteristic finding is that all BB3/TiyA + y/b clones mediate strong cytolysis of Daudi cells but they do not lyse Raji cells. In contrast, NK clones from the same donors mediate strong cytolysis of both Daudi and Raji targets. Cytotoxicity by the 'Y/b clones on certain target cells such as Daudi and Molt 4 can be specifically inhibited by mAbs reactive against the TCR-y/& Therefore, the TCR-y/b on these clones either directly recognizes target epitopes on some tumor targets or it is involved in the regulation of their cytotoxic function . The expression of TCR-y/b products reacting with the BB3 and TiyA mAbs reflects the usage of identical TCRy/b V region genes that appear to be associated with the characteristic pattern ofnon-MHC-restricted cytotoxicity displayed by this major subset of human peripheral blood y/b cells.
